Previous 10 | Next 10 |
Dr. Aric Coffman joins P3 Health Partners as CEO Total revenue growth of 29% year-over-year Reaffirming 2024 guidance Anticipates reaching Adjusted EBITDA positive in 2024 Management to Host Conference Call and Webcast May 8, 2024 at 4:30 PM ET P3 Health ...
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), today named Dr. Aric Coffman as P3’s Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3’s Co-Founder. Dr. Abdou will continue to serve as a Strategic Adviso...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2024 and file its Quarterly Report on Form 10-Q on Wednesday, May 8, 20...
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the 23 rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 1:30 pm Eas...
2024-04-01 12:16:04 ET More on P3 Health Partners P3 Health Partners Inc. (PIII) Q4 2023 Earnings Call Transcript P3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimates Seeking Alpha’s Quant Rating on P3 Health Partners Historica...
2024-03-28 22:04:09 ET P3 Health Partners Inc. (PIII) Q4 2023 Results Conference Call March 28, 2024 4:30 PM ET Company Participants Ryan Halsted - Gilmartin Group Sherif Abdou - Co-Founder, CEO Atul Kavthekar - CFO Amir Bacchus - CMO Bill Bettermann - CO...
2024-03-28 16:18:07 ET More on P3 Health Partners P3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimates Seeking Alpha’s Quant Rating on P3 Health Partners Historical earnings data for P3 Health Partners Financial information for...
Total revenue growth of 21% year-over-year, beating our 2023 guidance Affirming 2024 guidance Anticipates reaching Adjusted EBITDA positive in 2024 Management to Host Conference Call and Webcast March 28, 2024 at 4:30 PM ET P3 Health Partners Inc. (...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
News, Short Squeeze, Breakout and More Instantly...
P3 Health Partners Inc. Company Name:
PIII Stock Symbol:
NASDAQ Market:
P3 Health Partners Inc. Website:
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, will participate at the following upcoming investor conferences: The William Blair 44 th Annual Growth Stock Conference in Chicago, IL on Tuesday, ...
P3 Health Partners Inc. (Nasdaq: PIII), a patient- centered and physician-led population health management company (the “Company”), today announced that it has entered into definitive agreements to sell securities in a private placement with certain institutional investors. The lead...